Dr. Fauzia Riaz is an Assistant Professor of Medicine at Stanford University whose research program focuses on biomarker-driven strategies to optimize the treatment of breast cancer, including the use of circulating tumor DNA in early-stage disease. Her work aims to improve outcomes for patients using biomarker-driven decisions to personalize therapy and through the better understanding care delivery models.